Two studies were conducted to ascertain the biologically effective dose (BED) of flumioxazin and pyroxasulfone for multiple herbicide–resistant (MHR) waterhemp [Amaranthus tuberculatus (Moq.) Sauer] control in soybean [Glycine max (L.) Merr.] in southwestern Ontario, Canada, during 2016 and 2017. In the flumioxazin study, the predicted flumioxazin doses for 50%, 80%, and 90% MHR A. tuberculatus control were 19, 37, and 59 g ai ha−1 at 2 wk after application (WAA) and 31, 83, and 151 g ai ha−1, respectively, at 12 WAA. The predicted flumioxazin doses to cause 5% and 10% soybean injury were 129 and 404 g ai ha−1, respectively, at 2 wk after emergence (WAE), and the predicted flumioxazin doses to obtain 50%, 80%, and 95% of the weed-free control plot’s yield were determined to be 3, 14, and 65 g ai ha−1, respectively. In the pyroxasulfone study, the predicted pyroxasulfone doses that provided 50%, 80%, and 90% MHR A. tuberculatus visible control were 25, 50, and 88 g ai ha−1 at 2 WAA and 41, 109, and 274 g ai ha−1 at 12 WAA, respectively. The dose of pyroxasulfone predicted for 80% reduction in MHR A. tuberculatus density was 117 g ai ha−1, and the doses of pyroxasulfone predicted for 80% and 90% reduction in A. tuberculatus biomass were 204 and 382 g ai ha−1, respectively. The predicted doses of pyroxasulfone that caused 5% and 10% injury in soybean at 2 WAE were 585 and 698 g ai ha−1, respectively. The predicted doses of pyroxasulfone required to obtain 50%, 80%, and 95% yield relative to the weed-free plots were 6, 24, and 112 g ai ha−1, respectively. Flumioxazin and pyroxasulfone applied preemergence at the appropriate doses provided early-season MHR A. tuberculatus control in soybean.

Photosystem II (PS II)-inhibitor herbicide resistance in Ontario waterhemp [Amaranthus tuberculatus (Moq.) Sauer] populations is conferred via target-site resistance (TSR) and non–target site resistance (NTSR) mechanisms. Metribuzin-resistant (MR) A. tuberculatus is due to TSR. Conversely, in other populations of PS II–inhibitor resistant A. tuberculatus, plants are resistant to atrazine but metribuzin sensitive (MS). The objective of this study was to determine the biologically effective dose of metribuzin applied preemergence and postemergence for the control of MS and MR A. tuberculatus. Ten field experiments were conducted in 2019 and 2020 to determine the effective doses of metribuzin for 50%, 80%, and 95% control of MS and MR A. tuberculatus. Metribuzin applied preemergence at the calculated doses of 133, 350, and 1,070 g ai ha−1 controlled MS A. tuberculatus 50%, 80%, and 95%, respectively, whereas the calculated doses of 7,868 and 17,533 g ai ha−1 controlled MR A. tuberculatus 50% and 80%, respectively, at 12 wk after application (WAA). Metribuzin applied postemergence at the calculated doses of 245 and 1,480 g ai ha−1 controlled MS A. tuberculatus 50% and 80%, respectively; the calculated dose for 50% MR A. tuberculatus control was greater than the highest dose (17,920 g ai ha−1) included in this study. Metribuzin at 560 and 1,120 g ha−1 and pyroxasulfone/flumioxazin (240 g ai ha−1) applied preemergence controlled MS A. tuberculatus 88%, 95%, and 98%, respectively, at 12 WAA, whereas the same treatments only controlled MR A. tuberculatus 0%, 4%, and 93%, respectively, at 12 WAA. Metribuzin at 560 and 1,120 g ha−1 and fomesafen (240 g ai ha−1) applied postemergence controlled MS A. tuberculatus 65%, 70%, and 78%, and MR A. tuberculatus 0%, 1%, and 49%, respectively, at 12 WAA. Based on these results, PS II–inhibitor resistant A. tuberculatus with NTSR (enhanced metabolism) is controlled with metribuzin applied preemergence and postemergence; in contrast, PS II–inhibitor resistant A. tuberculatus with TSR (glycine-264-serine altered target site) is not controlled with metribuzin.

Tiafenacil is a recently developed protoporphyrinogen IX oxidase (PPO)-inhibiting herbicide from the pyrimidinedione chemical class that is proposed for use as a preplant (PP) burndown in soybean. Glyphosate-resistant (GR) horseweed is a troublesome weed often found in no-till systems that can dramatically reduce soybean yield; control in soybean has been variable. Five field experiments were conducted over 2019 and 2020 in commercial soybean fields with GR horseweed to determine the biologically effective dose (BED) of tiafenacil and tiafenacil + metribuzin and to compare their efficacy to currently accepted industry standard herbicide treatments in identity-preserved (IP, non-GMO), GR, and glyphosate/dicamba-resistant (GDR) soybean systems. There was no soybean injury with treatments evaluated. The calculated doses of tiafenacil for 50%, 80%, and 95% control of GR horseweed control were 21, 147, and >200 g ai ha−1, respectively, at 8 wk after application (WAA). Lower doses were calculated with the addition of metribuzin (400 g ai ha−1) to tiafenacil for 50% and 80% control, with no dose of tiafenacil + metribuzin providing 95% control. Tiafenacil + metribuzin at 25 + 400 and 50 + 400 g ai ha−1 controlled GR horseweed 88% and 93%, respectively, which was similar to the industry standards of saflufenacil + metribuzin (25 + 400 g ai ha−1) and glyphosate/dicamba + saflufenacil (1,200/600 + 25 g ai ha−1) that provided 98% and 100% control, respectively, at 8 WAA. This study presents the potential utility of tiafenacil + metribuzin as a GR horseweed management strategy in soybean.

Glyphosate-resistant (GR) horseweed was first confirmed in Ontario in 2010. GR horseweed interference can reduce soybean yield by up to 97%. Bromoxynil is a photosystem II–inhibiting herbicide that is primarily used for annual broadleaf weed control in monocot crops. The objective of this study was to determine the biologically effective dose (BED) of bromoxynil applied alone and when mixed with metribuzin applied preplant for control of GR horseweed in soybean in Ontario. Five field experiments were conducted over a 2-yr period (2019–2020) to determine the predicted dose of bromoxynil with or without metribuzin that would control GR horseweed 50%, 80%, and 95%. No soybean injury was observed. The predicted doses of bromoxynil to achieve 50% and 80% control of GR horseweed were 98 and 277 g ai ha−1, respectively, at 8 wk after application (WAA). When mixed with metribuzin (400 g ai ha−1), the predicted doses of bromoxynil for 50%, 80%, and 95% control of GR horseweed were 10, 25, and 54 g ai ha−1, respectively. Bromoxynil (280 g ai ha−1) plus metribuzin (400 g ai ha−1) controlled GR horseweed 97%, a finding that was similar to the industry standards of saflufenacil + metribuzin (99% control) and glyphosate/dicamba + saflufenacil (100% control) at 8 WAA. This study concludes that bromoxynil + metribuzin applied before planting provides excellent control of GR horseweed in soybean.

Les approches centrées sur l’autorégulation ainsi que sur l’acceptation des émotions et des sensations désagréables inspirées des programme MBSR et MBCT, représentent une voie intéressante dans la prise en charge des troubles du comportement alimentaire dans lesquels le contrôle et l’évitement sont au premier plan. Ces programmes permettent de travailler les aspects obsessionnels (comme les ruminations) et compulsifs (sur l’alimentation, la réactivité avec perte de contrôle) associés à ces troubles alimentaires. La clinique des maladies mentales et de l’encéphale (CMME), hôpital Sainte-Anne a mis en place un protocole « MBCT Boulimie » en huit séances. Le programme MBCT a été modifié, notamment au niveau des outils cognitifs et de la durée des pratiques de méditation pour des patients présentant un TCA. La recherche s’est réalisée sur vingt-quatre sujets de l’hôpital de jour de la CMME et avait pour objet d’évaluer l’impact du programme MBCT dans une population de sujets souffrant de boulimie et de Binge Eating Disorder.

This narrative review provides an overview of the epidemiology of binge eating disorder (BED), highlighting the medical history of this disorder and its entry as an independent condition in the Feeding and Eating Disorders section of the recently published Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Estimates of prevalence are provided, as well as recognition that the female to male ratio is lower in BED than in other eating disorders. Evidence is also provided of the most common comorbidities of BED, including mood and anxiety disorders and a range of addiction disorders. In addition, discussion of the viewpoint that BED itself may be an addiction — at least in severe cases — is presented. Although the genetic study of BED is still in its infancy, current research is reviewed with a focus on certain neurotransmitter genes that regulate brain reward mechanisms. To date, a focal point of this research has been on the dopamine and the μ-opioid receptor genes. Preliminary evidence suggests that a predisposing risk factor for BED may be a heightened sensitivity to reward, which could manifest as a strong dopamine signal in the brain’s striatal region. Caution is encouraged, however, in the interpretation of current findings, since samples are relatively small in much of the research. To date, no genome-wide association studies have focused exclusively on BED.

A specially designed specimen holder employing a beryllium dome has been fabricated for collection of X-ray diffraction (XRD) data from highly reactive materials. The specimen holder has a robust O-ring type seal (<10−9Torr) and no observed intensity artifacts in the 1° to 150° 2θ range. The design also minimizes specimen displacement errors and allows for analysis of both powders and bulk specimens (i.e., pellets). The simple design makes for straightforward assembly of the holder within the confines of a glove box. XRD analysis of hygroscopic LaBr3 powders collected with this holder are suitable for Rietveld structure refinement, yielding unit cell lattice parameters of a=7.9703(6) Å and c=4.5122(6) Å; cell volume=248.44(6) Å3; Rp=7.70%.